ArticleChemosensors (Basel, Switzerland)2023
Progress on Electrochemical Sensing of Pharmaceutical Drugs in Complex Biofluids.
Article in Chemosensors (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Clinical Laboratory Innovations: Nanoscale Detection of Chloramphenicol Using Nanomaterial Biosensors.Analytical science advances · 2026Review
- Article
- A Novel Approach for Optimizing Molecularly Imprinted Polymer Composition in Electrochemical Detection of Collagen Peptides.Bioengineering (Basel, Switzerland) · 2025Article
- Microplastics in human body: accumulation, natural clearance, and biomedical detoxification strategies.Biomedical engineering letters · 2025Review
- Article
- Machine Learning Applied to Electrochemical Data Processing for Improved Analyte Quantification in Complex Saliva.Electroanalysis · 2025Article
- Applications of Carbon-Based Multivariable Chemical Sensors for Analyte Recognition.Nano-micro letters · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Electrochemical detection, with its advantages of being rapid, multi-time point, compatible with cost-effective fabrication methods, and having the potential for miniaturization and portability, has great promise for point-of-care drug monitoring. However, a continuing challenge concerns the robust and sensitive electrochemical detection of pharmaceutical analytes from biological fluids. These complex matrices, such as saliva, sweat, interstitial fluid, urine, and blood/serum, contain multiple components that can contribute to an increased background or reduced analyte signal. In this mini-review, we discuss progress on electrochemical sensing in complex biofluids. We first introduce the challenge of drug titration in the management of various health conditions and provide an overview of the motivation for improved therapeutic drug monitoring, including current limitations. We then review progress on pharmaceutical drug detection from these biofluids with a focus on sample preprocessing, electrode modification for signal amplification, and/or electrode passivation to minimize fouling. Finally, we highlight promising strategies that have enabled robust drug quantification for clinical relevance and that may be useful for field-use systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.